EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma
EGFR is frequently constitutively active in glioblastoma (GBM). Here, the authors show that EGFR induces YTHDF2 protein stabilization, which reduces cholesterol homeostasis through an RNA m6A methylation dependent molecular mechanism to promote GBM tumourigenesis.
Guardado en:
Autores principales: | Runping Fang, Xin Chen, Sicong Zhang, Hui Shi, Youqiong Ye, Hailing Shi, Zhongyu Zou, Peng Li, Qing Guo, Li Ma, Chuan He, Suyun Huang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dbb72d0750a2491f8e7c06b1a87b4c5f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Morphine promotes microglial activation by upregulating the EGFR/ERK signaling pathway.
por: Yaqiong Yang, et al.
Publicado: (2021) -
Lamellipodin-RICTOR Signaling Mediates Glioblastoma Cell Invasion and Radiosensitivity Downstream of EGFR
por: Stefanie Moritz, et al.
Publicado: (2021) -
Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma
por: Leland S. Hu, et al.
Publicado: (2021) -
YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
por: Yulin Shi, et al.
Publicado: (2019) -
Deletion of TSPO Causes Dysregulation of Cholesterol Metabolism in Mouse Retina
por: Fahad Farhan, et al.
Publicado: (2021)